FDA’s approval this week of Lilly’s nasal glucagon (Baqsimi) is a true game changer. No more reconstitution!! It comes in portable, compact package containing fixed 3 mg dose. The list price is $280.80 for one pack and $561.60 for two pack. It is approved for treatment of severe hypoglycemia in persons four years of age and older. Baqsimi should be available within pharmacies within a month.
Please share your thoughts and subscribe to receive my blogs.
#nasal #glucagon #severe #hypoglycemia #Lilly
Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram ReecesPiecesDI.